DE3323264C2 - Arzneimittel zur Behandlung von vaskulären Erkrankungen - Google Patents

Arzneimittel zur Behandlung von vaskulären Erkrankungen

Info

Publication number
DE3323264C2
DE3323264C2 DE3323264A DE3323264A DE3323264C2 DE 3323264 C2 DE3323264 C2 DE 3323264C2 DE 3323264 A DE3323264 A DE 3323264A DE 3323264 A DE3323264 A DE 3323264A DE 3323264 C2 DE3323264 C2 DE 3323264C2
Authority
DE
Germany
Prior art keywords
diseases
hda
heart
treatment
cardiovascular diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE3323264A
Other languages
German (de)
English (en)
Other versions
DE3323264A1 (de
Inventor
Nobuo Tokio/Tokyo Mochida
Haruo Funabashi Chiba Ohnishi
Yasuo Kawaguchi Saitama Suzuki
Kazuo Koganei Tokio/Tokyo Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mochida Pharmaceutical Co Ltd
Original Assignee
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharmaceutical Co Ltd filed Critical Mochida Pharmaceutical Co Ltd
Publication of DE3323264A1 publication Critical patent/DE3323264A1/de
Application granted granted Critical
Publication of DE3323264C2 publication Critical patent/DE3323264C2/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D315/00—Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups C07D303/00 - C07D313/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE3323264A 1982-06-28 1983-06-28 Arzneimittel zur Behandlung von vaskulären Erkrankungen Expired DE3323264C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57111183A JPS591415A (ja) 1982-06-28 1982-06-28 循環系疾患治療剤

Publications (2)

Publication Number Publication Date
DE3323264A1 DE3323264A1 (de) 1984-01-05
DE3323264C2 true DE3323264C2 (de) 1986-03-06

Family

ID=14554592

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3323264A Expired DE3323264C2 (de) 1982-06-28 1983-06-28 Arzneimittel zur Behandlung von vaskulären Erkrankungen

Country Status (11)

Country Link
US (1) US4578400A (US06826419-20041130-M00005.png)
JP (1) JPS591415A (US06826419-20041130-M00005.png)
AU (1) AU546935B2 (US06826419-20041130-M00005.png)
CA (1) CA1209921A (US06826419-20041130-M00005.png)
CH (1) CH660556A5 (US06826419-20041130-M00005.png)
DE (1) DE3323264C2 (US06826419-20041130-M00005.png)
FR (1) FR2529081B1 (US06826419-20041130-M00005.png)
GB (1) GB2123691B (US06826419-20041130-M00005.png)
IT (1) IT1173725B (US06826419-20041130-M00005.png)
NL (1) NL187299C (US06826419-20041130-M00005.png)
SE (1) SE462419B (US06826419-20041130-M00005.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2665737B2 (ja) * 1986-05-27 1997-10-22 宇部興産株式会社 微粒子状無機フイラー分散液の製造法
CA2016467A1 (en) 1989-06-05 1990-12-05 Martin Eisman Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
AU2003278212B2 (en) * 2002-07-31 2009-07-09 Centre National De La Recherche Scientifique Stem cells derived from adipous tissue and differentiated cells derived from said cells
DE602004029362D1 (de) * 2003-06-18 2010-11-11 Inst Cardiologie De Montreal M Vermeidung von vorhofflimmern (af) mit der verwendung von statin
DE102004052697A1 (de) * 2004-10-29 2006-05-04 Haehner, Thomas, Dr. Pharmazeutische Zubereitungen zur Behandlung von Folgen des Alkoholmissbrauchs, Hepatitis, Pankreatitis, Alzheimererkrankung, Morbus Parkinson, Diabetes, toxischen Nierenerkrankungen, Reperfusionsschäden, der Arteriosklerose sowie als Antidote gegen Umweltgifte und Medikamentenintoxikation
DK1855674T3 (da) * 2005-03-02 2014-10-20 Merck Sharp & Dohme Sammensætning til hæmning af cathepsin k
DE102006019906A1 (de) * 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptable Salze zur Herstellung einer pharmazeutischen Zubereitung
EP2832732B1 (en) * 2012-03-27 2019-07-24 Tsujimoto Chemical Co., Ltd. Ppars agonist activity enhancing drug
BR112019020785A2 (pt) * 2017-04-10 2020-04-28 Ucl Business Plc composição para uso no tratamento da epilepsia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1417119A (en) * 1972-11-30 1975-12-10 Thiele G H Process for treating bones
US4225501A (en) * 1977-07-25 1980-09-30 Givaudan Corporation 1,4-Epoxy-1,3,3-trimethyl-2-(2-buten-1-ylidene)-cyclohexanes
US4357315A (en) * 1980-08-07 1982-11-02 International Flavors & Fragrances Inc. Use of 1-ethoxy-1-ethanol acetate for augmenting or enhancing the taste of toothpaste

Also Published As

Publication number Publication date
SE8303700D0 (sv) 1983-06-28
FR2529081B1 (fr) 1985-11-15
US4578400A (en) 1986-03-25
IT8348588A0 (it) 1983-06-28
NL187299B (nl) 1991-03-18
NL187299C (nl) 1991-08-16
AU546935B2 (en) 1985-09-26
FR2529081A1 (fr) 1983-12-30
NL8302273A (nl) 1984-01-16
CH660556A5 (de) 1987-05-15
AU1631583A (en) 1984-01-05
JPS591415A (ja) 1984-01-06
CA1209921A (en) 1986-08-19
IT1173725B (it) 1987-06-24
DE3323264A1 (de) 1984-01-05
JPH0142246B2 (US06826419-20041130-M00005.png) 1989-09-11
GB8317357D0 (en) 1983-07-27
SE462419B (sv) 1990-06-25
GB2123691A (en) 1984-02-08
GB2123691B (en) 1985-07-31
SE8303700L (sv) 1983-12-29

Similar Documents

Publication Publication Date Title
DE60212786T2 (de) Verwendung mehrfach ungesättigter Fettsäuren zur primären Prävention kardiovaskulärer Ereignisse
DE602004010531T2 (de) Verwendung von fumarsäure-derivaten zur behandlung von herzinsuffizienz und asthma
DE2907778A1 (de) Verwendung von phosphatidylverbindungen in arzneimitteln gegen wahrnehmungs-, bewusstseins- und bewegungsstoerungen
EP0282696B1 (de) Verwendung von Pyridoxin-Derivaten bei der Prophylaxe und Therapie von Hyperlipidämien und Atherosklerose
DE68904507T2 (de) Verwendung von inositoltriphosphat bei der behandlung der beschaedigung von gewebe.
DE3323264C2 (de) Arzneimittel zur Behandlung von vaskulären Erkrankungen
DE2528360A1 (de) Neue pyrimidine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
DE69821524T2 (de) Verwendung von vitis vinifera extrakten phospholipid komplexen als antiatherosclerotische mitteln
DE69907509T2 (de) Pphospholipidkomplexe von proanthocyanidin a2 als antiatherosklerotische mittel
DE2514335C3 (de) Oral zu verabreichendes Arzneimittel mit Antiplasmin-Inhibitorwirkung
AT396588B (de) Verfahren zur herstellung von therapeutisch wirksamen ethern polycyclischer verbindungen
DE1767163A1 (de) Pharmazeutisches Praeparat
DE2206570B2 (de) Verwendung von ( + ) - Catechin
DE3873210T2 (de) Verwendung von benzylpyridin-derivaten zur herstellung eines arzneimittels zur behandlung der demenz.
DE2748291C3 (de) Substituierte 13-Benzodioxan-4one und Verfahren zu ihrer Herstellung sowie Verwendung dieser Verbindungen bei der Bekämpfung von Entzündungen
DE69937574T2 (de) Verwendung des pharmazeutischen präparates "histochrome" zur behandlung des akuten herzinfarkts und ischämischer herzerkrankungen
DE2527552A1 (de) Mittel zur behandlung von krankheitszustaenden, die durch demyelierungsprozesse oder hypercholinergie bedingt werden
EP0509042B1 (de) Intravenös applizierbare Pharmazeutische Zubereitung von 1-Octadecyl-2-methyl-glycero3-phosphocholin
DE2625053C3 (de) Arzneimittel zur Kontrolle von Leberkrankheiten
DE3315482A1 (de) Mittel zur verhinderung und behandlung von blutlipid-abnormalitaet und/oder arteriosclerose
DE3048154C2 (US06826419-20041130-M00005.png)
DE3244806C2 (US06826419-20041130-M00005.png)
DE3306299C2 (US06826419-20041130-M00005.png)
DE3141970A1 (de) Arzneimittel zur behandlung der durch den virus der herpes-gruppe erzeugten erkrankungen
DE3406837C2 (US06826419-20041130-M00005.png)

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee